We are excited to announce that our abstract, titled “Performance characteristics of a new, fully automated planar microarray immunoassay for the detection of autoantibodies against Centromere Protein B and correlations with autoimmune disease diagnosis” will be presented at the 2023 Dresden Symposium on Autoantibodies, in Germany.
The study demonstrated that the MosaiQ® Centromere Protein B Microarray provides a high level of concordance with other CE-marked assays for detecting Centromere Protein B autoantibodies, with high reproducibility and repeatability.
Would you like to know more about MosaiQ, our Autoimmune diagnostic solution? Meet us at the 2023 Dresden Symposium on Autoantibodies (https://www.gfid-ev.de/dsa.htm), booth 12.
